New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases

New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases

FDA approves another Herceptin biosimilar in blow to Roche

FDA approves another Herceptin biosimilar in blow to Roche

Pfizer secures 4th cancer drug approval in 2 months

Pfizer secures 4th cancer drug approval in 2 months

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years

Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years